Back

Clinical outcomes and impact of mitral valve surgery in atrial functional mitral regurgitation: the REVEAL-AFMR registry

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Challenging decisions in valvular heart surgery Mitral Valve Regurgitation ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Associate Professor Nobuyuki Kagiyama

Juntendo University School of Medicine, Tokyo (Japan)

3 More presentations in this session

Presentation thumbnail
Mitral valve reoperation versus first-time surgery for mitral regurgitation: comparison of patient characteristics, type of surgery and mortality in a nationwide cohort
Ms S. Truong (Copenhagen University Hospital, DK)
Abstract Slides Video
Presentation thumbnail
Validation of the MIDA mortality risk score in a surgical cohort of patients with primary mitral regurgitation.
Doctor P. O'Neill Gonzalez (Hermosillo Sonora, MX)
Abstract Slides Video
Presentation thumbnail
Evolution and prognostic relevance of right ventricular morphofunctional parameters in patients undergoing isolated tricuspid valve surgery
Doctor M. Luque (Santiago, CL)
Abstract Slides Video

Access the full session

Session thumbnail
Challenging decisions in valvular heart surgery

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Effect of severe tricuspid regurgitation on the prognosis of patients with atrial functional mitral regurgitation: the REVEAL-AFMR registry
thumbnail
Congress Session
Atrial functional mitral regurgitation: underappreciated and underdiagnosed
thumbnail
Congress Presentation
Advances in HFrEF and HFpEF

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources